These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 25193861)
1. Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer. Roh JL; Kim EH; Park JY; Kim JW; Kwon M; Lee BH Oncotarget; 2014 Oct; 5(19):9227-38. PubMed ID: 25193861 [TBL] [Abstract][Full Text] [Related]
2. A Novel Polyphenol Conjugate Sensitizes Cisplatin-Resistant Head and Neck Cancer Cells to Cisplatin via Nrf2 Inhibition. Kim EH; Jang H; Roh JL Mol Cancer Ther; 2016 Nov; 15(11):2620-2629. PubMed ID: 27550943 [TBL] [Abstract][Full Text] [Related]
3. Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer. Kim EH; Jang H; Shin D; Baek SH; Roh JL Apoptosis; 2016 Nov; 21(11):1265-1278. PubMed ID: 27544755 [TBL] [Abstract][Full Text] [Related]
4. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer. Roh JL; Park JY; Kim EH; Jang HJ; Kwon M Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904 [TBL] [Abstract][Full Text] [Related]
5. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Roh JL; Kim EH; Jang H; Shin D Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440 [TBL] [Abstract][Full Text] [Related]
6. Targeting acid ceramidase sensitises head and neck cancer to cisplatin. Roh JL; Park JY; Kim EH; Jang HJ Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835 [TBL] [Abstract][Full Text] [Related]
7. Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogen-activated protein kinase-dependent mitochondrial reactive oxygen species. Kang SU; Cho JH; Chang JW; Shin YS; Kim KI; Park JK; Yang SS; Lee JS; Moon E; Lee K; Kim CH Cell Death Dis; 2014 Feb; 5(2):e1056. PubMed ID: 24525732 [TBL] [Abstract][Full Text] [Related]
8. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer. Roh JL; Kim EH; Jang HJ; Park JY; Shin D Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897 [TBL] [Abstract][Full Text] [Related]
9. The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer. Roh JL; Ko JH; Moon SJ; Ryu CH; Choi JY; Koch WM Cancer Lett; 2012 Dec; 325(1):35-41. PubMed ID: 22634494 [TBL] [Abstract][Full Text] [Related]
10. Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1. Hang W; Yin ZX; Liu G; Zeng Q; Shen XF; Sun QH; Li DD; Jian YP; Zhang YH; Wang YS; Quan CS; Zhao RX; Li YL; Xu ZX Oncogene; 2018 Jun; 37(25):3384-3398. PubMed ID: 29348462 [TBL] [Abstract][Full Text] [Related]
11. Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells. Zhang P; Shi L; Zhang T; Hong L; He W; Cao P; Shen X; Zheng P; Xia Y; Zou P Cell Oncol (Dordr); 2019 Dec; 42(6):847-860. PubMed ID: 31493144 [TBL] [Abstract][Full Text] [Related]
12. RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems. Shin D; Kim EH; Lee J; Roh JL Redox Biol; 2017 Oct; 13():219-227. PubMed ID: 28582730 [TBL] [Abstract][Full Text] [Related]
13. XI-011 enhances cisplatin-induced apoptosis by functional restoration of p53 in head and neck cancer. Roh JL; Park JY; Kim EH Apoptosis; 2014 Nov; 19(11):1594-602. PubMed ID: 25113507 [TBL] [Abstract][Full Text] [Related]
14. Hederagenin Induces Apoptosis in Cisplatin-Resistant Head and Neck Cancer Cells by Inhibiting the Nrf2-ARE Antioxidant Pathway. Kim EH; Baek S; Shin D; Lee J; Roh JL Oxid Med Cell Longev; 2017; 2017():5498908. PubMed ID: 29456786 [TBL] [Abstract][Full Text] [Related]
15. The Hsp90 inhibitor 17-(allylamino)-17-demethoxygeldanamycin increases cisplatin antitumor activity by inducing p53-mediated apoptosis in head and neck cancer. Roh JL; Kim EH; Park HB; Park JY Cell Death Dis; 2013 Dec; 4(12):e956. PubMed ID: 24336076 [TBL] [Abstract][Full Text] [Related]
16. Piperlongumine induces G2/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway. Thongsom S; Suginta W; Lee KJ; Choe H; Talabnin C Apoptosis; 2017 Nov; 22(11):1473-1484. PubMed ID: 28913568 [TBL] [Abstract][Full Text] [Related]
17. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Raj L; Ide T; Gurkar AU; Foley M; Schenone M; Li X; Tolliday NJ; Golub TR; Carr SA; Shamji AF; Stern AM; Mandinova A; Schreiber SL; Lee SW Nature; 2011 Jul; 475(7355):231-4. PubMed ID: 21753854 [TBL] [Abstract][Full Text] [Related]
18. Piperlongumine induces gastric cancer cell apoptosis and G2/M cell cycle arrest both in vitro and in vivo. Duan C; Zhang B; Deng C; Cao Y; Zhou F; Wu L; Chen M; Shen S; Xu G; Zhang S; Duan G; Yan H; Zou X Tumour Biol; 2016 Aug; 37(8):10793-804. PubMed ID: 26874726 [TBL] [Abstract][Full Text] [Related]
19. Curcuminoid WZ26, a TrxR1 inhibitor, effectively inhibits colon cancer cell growth and enhances cisplatin-induced cell death through the induction of ROS. Zhang T; Zheng P; Shen X; Shao R; Wang B; Shen H; Zhang J; Xia Y; Zou P Free Radic Biol Med; 2019 Sep; 141():93-102. PubMed ID: 31176737 [TBL] [Abstract][Full Text] [Related]
20. Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition. Roh JL; Kim EH; Jang H; Shin D Free Radic Biol Med; 2017 Mar; 104():1-9. PubMed ID: 28057599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]